Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Johnson

Showing results (111-120 of 221) with videos related to

Pageof 23
Sort By:
The New England Journal of Medicine|January 11, 2002
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancerJoan H Schiller, David Harrington, Chandra P Belani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Cancer|September 19, 2002
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North AmericaPasi A Jänne, Boris Freidlin, Scott Saxman, et al.
Canadian Respiratory Journal|September 4, 2003
Hospitalization for community-acquired pneumonia in Alberta patients with human immunodeficiency virus infections: a case control studyDavid H Johnson, Keumhee C Carriere, Stan Houston, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2007
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500)Kishan J Pandya, Suzanne Dahlberg, Manuel Hidalgo, et al.
The New England Journal of Medicine|December 15, 2006
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerAlan Sandler, Robert Gray, Michael C Perry, et al.
Cancer Research|October 5, 2006
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonismLi Yang, Yuhui Huang, Rut Porta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 studyTien Hoang, Suzanne E Dahlberg, Joan H Schiller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2017
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and ComplexitySandra Garcia, Ajit Bisen, Jingsheng Yan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594Heather A Wakelee, Wei Wang, Joan H Schiller, et al.
Pageof 23

Showing results (111-120 of 221) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|January 11, 2002
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancerJoan H Schiller, David Harrington, Chandra P Belani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Cancer|September 19, 2002
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North AmericaPasi A Jänne, Boris Freidlin, Scott Saxman, et al.
Canadian Respiratory Journal|September 4, 2003
Hospitalization for community-acquired pneumonia in Alberta patients with human immunodeficiency virus infections: a case control studyDavid H Johnson, Keumhee C Carriere, Stan Houston, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2007
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500)Kishan J Pandya, Suzanne Dahlberg, Manuel Hidalgo, et al.
The New England Journal of Medicine|December 15, 2006
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerAlan Sandler, Robert Gray, Michael C Perry, et al.
Cancer Research|October 5, 2006
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonismLi Yang, Yuhui Huang, Rut Porta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 studyTien Hoang, Suzanne E Dahlberg, Joan H Schiller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2017
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and ComplexitySandra Garcia, Ajit Bisen, Jingsheng Yan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594Heather A Wakelee, Wei Wang, Joan H Schiller, et al.
Pageof 23